tradmap

CYTK Earnings Cytokinetics Inc

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$7 -$3 $1 $0 2016 2016 2016 2017 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $47M $95M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$785M -$384M $16M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$5 -$3 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $33M $67M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$306M -$153M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–34 of 34
Q2 20262026-06-30-3.172026-08-0610-Q
Q1 20262026-03-31-1.672026-05-0510-Q
FY 20252025-12-31-6.542026-02-2610-K
Q3 20252025-09-30-5.042025-11-0510-Q
Q2 20262025-06-30-2.492026-08-0610-Q
Q1 20262025-03-31-1.362026-05-0510-Q
FY 20252024-12-31-5.262026-02-2610-K
Q3 20252024-09-30-4.002025-11-0510-Q
Q2 20252024-06-30-2.632025-08-0710-Q
Q1 20252024-03-31-1.332025-05-0610-Q
FY 20252023-12-31-5.452026-02-2610-K
Q3 20242023-09-30-4.072024-11-0710-Q
Q2 20242023-06-30-2.722024-08-0910-Q
Q1 20242023-03-31-1.382024-05-1010-Q
FY 20242022-12-31-4.332025-02-2710-K
Q3 20232022-09-30-2.852023-11-0310-Q
Q2 20232022-06-30-1.282023-08-0310-Q
Q1 20232022-03-31-1.052023-05-0510-Q
FY 20232021-12-31-2.802024-02-2810-K
Q3 20222021-09-30-2.482022-11-0410-Q
Q2 20222021-06-30-1.522022-08-0510-Q
FY 20222020-12-31-1.972023-03-0110-K
FY 20172017-12-31-2.592018-03-0510-K
Q3 20172017-09-30-1.822017-11-0310-Q
FY 20172016-12-310.392018-03-0510-K
FY 20172016-09-300.772018-03-0510-K
FY 20172016-06-30-0.292018-03-0510-K
FY 20172016-03-31-0.312018-03-0510-K
FY 20172015-12-31-0.972018-03-0510-K
Q3 20162015-09-30-0.732016-11-0310-Q
FY 20162014-12-31-0.412017-03-0610-K
FY 20112011-12-31-0.722012-03-1310-K
FY 20112010-12-31-0.772012-03-1310-K
FY 20112009-12-310.422012-03-1310-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.